SCHEMBL3486145

SCHEMBL3486145

[CH2]CC(O)c1ccc(OC)c(O)c1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 1/20 0.37
▸ ADRA1A P35348 1/20 0.37
▸ AOC3 Q16853 1/20 0.37
▸ CYP3A4 P08684 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ MCL1 Q07820 1/20 0.34
▸ ERN1 O75460 1/20 0.33
▸ NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3485146 0.80 CTSA (0.38) MAPTKDM4EALDH1A1ALOX15MAPK1
SCHEMBL13748939 0.78 CA1 (0.44) CYP3A4MAPTKDM4EALDH1A1LMNA
SCHEMBL10905476 0.72 RAB9A (0.47) ADRA2AADRA1ACYP3A4ALDH1A1LMNA
SCHEMBL1520565 0.70 ADRA1A (0.54) ADRA2AADRA1AAOC3MAPTALDH1A1
SCHEMBL5469559 0.69 MAPK1 (0.52) CYP3A4MAPTKDM4EALDH1A1LMNA
SCHEMBL9335491 0.69 MAPK1 (0.46) CYP3A4MAPTKDM4EALDH1A1LMNA
SCHEMBL12957854 0.67 MAPT (0.45) CYP3A4MAPTKDM4EALDH1A1LMNA
SCHEMBL15105506 0.67 ACHE (0.43) CYP3A4MAPTKDM4EALDH1A1LMNA
SCHEMBL6571131 0.66 IDO1 (0.44) CYP3A4MAPTKDM4EALDH1A1LMNA
SCHEMBL16704713 0.66 MAPT (0.43) CYP3A4MAPTKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100028952-A1 FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES WYETH (US) 2010-02-04 — — US disclosed
EP-2029175-A2 FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES Wyeth (US) 2009-03-04 — — EP disclosed
US-20080274959-A1 Actinomadura Chromoprotein, Apoprotein and Gene Cluster WYETH (US) 2008-11-06 — — US disclosed
WO-2007149560-A9 FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES WYETH CORP (US) 2008-07-24 — — WO disclosed
WO-2007149560-A2 FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES WYETH (US) 2007-12-27 — — WO disclosed
EP-1836219-A2 ACTINOMADURA CHROMOPROTEIN, APOPROTEIN, AND GENE CLUSTER Wyeth (US) 2007-09-26 — — EP disclosed
WO-2006066153-A2 ACTINOMADURA CHROMOPROTEIN, APOPROTEIN, AND GENE CLUSTER WYETH (US) 2006-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080274959-A1 Actinomadura Chromoprotein, Apoprotein and Gene Cluster ACTR2, APOB, CACYBP ADRA2A 639/4885ADRA1A 1294/4885AOC3 1077/4885
US-20100028952-A1 FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES DCXR, ACTR2, AMY2A ADRA2A 901/4885ADRA1A 1681/4885AOC3 1936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback